Mumtada, Mass General Brigham team up on specialized rehab services: Mumtada Medical Company and Mass General Brigham will kick off operations at a facility in Riyadh for long-term post-acute care and rehabilitation by the end of 2024, as part of a new partnership agreement between the two, according to a statement (pdf).

What they’re building: The facility in Riyadh will have 200 beds, with 27 specialized clinics and 17 dialysis units, according to the statement. It will be supported by a diagnostics lab, pharmacy, radiology, and include both intensive care and high-dependency units serving adults and pediatrics.

It’s just the start: Mumtada is also developing other facilities in the country, the statement says, noting that it is in “advanced stages” on other announcements that will see it “rapidly expand” its footprint.

Who’s who: Mumtada is a specialized rehabilitation and long-term post-acute care company founded by Fawaz Alhokair, who is also Mumtada’s chairman. Mass General Brigham is a Massachusetts-based integrated healthcare network. The network includes several teaching, community, and specialist hospitals, as well as medical experts.

The market by the numbers: Mumtada, led by our friend CEO Aiman Shalbi, estimates that Saudi will need some 18k long-term care and rehabilitation beds by 2030, pegging the market as being worth up to USD 14 bn.

What the partnership will entail: The partnership will see “world-renowned physicians, therapists, nurses and subject-matter experts” from Mass General Brigham’s Spaulding Rehabilitation who will “actively engage in clinical programming, workforce plan development, quality plan development, information technology, and on-site commissioning support for Mumtada.”

What Mumtada is bringing to the table: “In this partnership, we will apply our understanding of the Saudi population, our ability to rapidly design, develop, build, operate, and scale large facilities and businesses,” Alhokair said.

Tags: